Survey for Usage Rates of Pertussis Vaccines in the State of Wisconsin
| Status: | Completed |
|---|---|
| Conditions: | Infectious Disease |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 3/16/2015 |
| Start Date: | February 2010 |
| End Date: | June 2015 |
| Contact: | Public Registry Sanofi Pasteur |
| Email: | RegistryContactUs@sanofipasteur.com |
Survey for Usage Rates of Pertussis Vaccines by Brand Among Persons Birth Through 59 Months of Age in the State of Wisconsin
The purpose of this study is to determine during the course of 5 years, the patterns of
pertussis vaccine usage by brand and dose among children birth through 59 months of age who
have received no more than four doses of pertussis vaccine, residing in the state of
Wisconsin.
The state of Wisconsin conducts comprehensive surveillance for pertussis disease. Data from
this brand exposure survey will be used to determine brand-specific rates of pertussis
disease among Wisconsin residents birth through 59 months of age.
pertussis vaccine usage by brand and dose among children birth through 59 months of age who
have received no more than four doses of pertussis vaccine, residing in the state of
Wisconsin.
The state of Wisconsin conducts comprehensive surveillance for pertussis disease. Data from
this brand exposure survey will be used to determine brand-specific rates of pertussis
disease among Wisconsin residents birth through 59 months of age.
This study supports the fulfillment of a post-licensure commitment to monitor
vaccine-specific rates of pertussis breakthrough disease among children given Pentacel
vaccine or other pertussis vaccines.
Ongoing telephone sample surveys will (with parental consent) collect brand-specific
pertussis vaccine/dosing information from health care providers of children living in the
catchment area.
These brand exposure data will be used, along with pertussis surveillance data, to satisfy
an FDA commitment to calculate brand-specific rates of pertussis disease during the study
period among persons birth through 59 months of age residing in Wisconsin.
No vaccines will be provided or administered for this study.
vaccine-specific rates of pertussis breakthrough disease among children given Pentacel
vaccine or other pertussis vaccines.
Ongoing telephone sample surveys will (with parental consent) collect brand-specific
pertussis vaccine/dosing information from health care providers of children living in the
catchment area.
These brand exposure data will be used, along with pertussis surveillance data, to satisfy
an FDA commitment to calculate brand-specific rates of pertussis disease during the study
period among persons birth through 59 months of age residing in Wisconsin.
No vaccines will be provided or administered for this study.
Inclusion Criteria :
- Persons will be eligible for inclusion in the survey population for this brand usage
study whenever the following three conditions are true: the individual resides in
Wisconsin, is age 2 through 59 months, and the date is within the 5-year survey
period
Exclusion Criteria :
- Not applicable.
We found this trial at
20
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials